Zynex acquires Kestrel Labs for $31M_老虎社区_美港股上老虎

Zynex acquires Kestrel Labs for $31M

seekingalpha2021-12-23

Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company. The transaction closed on December 22, 2021 at an approx. value of $31M, ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Yue7
·2021-12-24
Cool
回复
点赞
举报
chehe
·2021-12-23
[LOL]
回复
1
举报
kdcc
·2021-12-23
Pls like.. Thanks..
回复
3
举报
收起
- jub:
  Ok
  2021-12-23
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1122468807?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-23 22:15","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1122468807","market":"us","top_or_hot":-1,"title":"Zynex acquires Kestrel Labs for $31M","media":"seekingalpha","content":"<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZYXI","symbol_name":"Zynex, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","article_id":"1122468807","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","pubTimestamp":1640268939,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZYXI":"Zynex, Inc."},"translate_title":"Zynex以3100万美元收购Kestrel实验室","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZYXI":0.9},"content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":698952698,"gmtCreate":1640286479224,"gmtModify":1640286479327,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698952698","repostId":1122468807,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":698903278,"gmtCreate":1640271084685,"gmtModify":1640271084753,"author":{"id":"3566095201042840","authorId":"3566095201042840","name":"chehe","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3566095201042840","authorIdStr":"3566095201042840"},"htmlText":"[LOL]&nbsp;","listText":"[LOL]&nbsp;","text":"[LOL]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698903278","repostId":1122468807,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":698046272,"gmtCreate":1640269171009,"gmtModify":1640269171314,"author":{"id":"3582248787663478","authorId":"3582248787663478","name":"kdcc","avatar":"https://static.tigerbbs.com/6b7ab80d653c786d04ef593538824fd5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582248787663478","authorIdStr":"3582248787663478"},"htmlText":"Pls like.. Thanks..&nbsp;","listText":"Pls like.. Thanks..&nbsp;","text":"Pls like.. Thanks..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698046272","repostId":1122468807,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7090777,"gmtCreate":1640269591141,"gmtModify":1640269591178,"authorId":3578715828142222,"author":{"id":3578715828142222,"idStr":"3578715828142222","authorId":3578715828142222,"name":"jub","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":698046272,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":38,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}